Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (JDMF) for ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN-1 Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

    Client Email Product
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN-1

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 612Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Moehs Iberica
    Spain
    		 MOEHS IBERICA S. L. 228MF10136 MEPIVACAINE HYDROCHLORIDE 2016-07-27 2023-08-09 Cesar Martinell i Brunet 12A, Poligono Rubi Sur, Rubi (Barcelona), Spain
    26/09/2024 Siegfried AG
    Switzerland
    		 Siegfried Evionnaz SA 218MF10524 Mepivacaine hydrochloride 2006-05-18 2024-08-28 Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland